Variant · Snv
BIRC2 NM_001166.5(BIRC2):c.1517C>T (p.Ala506Val)
CI-VAR-00200213Explore in graph →p.Ala506ValNM_001166.5:c.1517C>TClinVar 1261128 rs34510872
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1261128 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Thalidomide response; Hepatocellular carcinoma; Malignant tumor of esophagus; Nonpapillary renal cell carcinoma; Adrenocortical carcinoma, hereditary; Malignant lymphoma, large B-cell, diffuse; Thymoma; Uterine carcinosarcoma; Acute myeloid leukemia; Cervical cancer | germline | 4 | Feb 17, 2020 | clinvar |